Influence
September 11, 2025

Healthy eating and physical activity significantly lower sex-specific alcohol-attributable liver mortality in the United States

Regenstrief Research Scientist Wanzhu Tu, PhD

Published in the Journal of Hepatology. Here is a link to the article. 

Regenstrief Institute author: Wanzhu Tu, PhD.

A new study analyzing national mortality data found that deaths from liver disease have increased in recent years, with the highest growth seen among adults under the age of 55. 

The analysis, which reviewed data from 1988 to 2019, showed that alcohol-associated liver disease accounted for the largest portion of deaths and experienced the fastest rate of increase. Nonalcoholic fatty liver disease was also identified as a steadily growing cause of liver-related deaths. 

After a period of stability, overall liver disease mortality began rising again starting in the mid-2000s, with a sharper increase observed between 2010 and 2019. The data indicate a shift in the burden of liver disease toward younger adults, emphasizing the importance of early identification and monitoring. 

The study provides updated national trends and identifies alcohol-associated and nonalcoholic fatty liver disease as the primary contributors to the recent increase in liver-related deaths. These findings can help guide future research, healthcare planning and prevention initiatives. 

Authors: 

Eduardo Vilar-Gomez1, Lauren Nephew1, Samer Gawrieh1, Raj Vuppalanchi1, Carla Kettler2, Francis Pike2, Wanzhu Tu2, Niharika Samala1, Suthat Liangpunsakul1,3, Naga Chalasani1   

Affiliations  

1Division of Gastroenterology and Hepatology, Department of Medicine, Indiana University School of Medicine, Indianapolis, IN, USA 

2Department of Biostatistics, Indiana University School of Medicine, Indianapolis, IN, USA 

3Roudebush Veterans Administration Medical Center, Indianapolis, IN, USA 

Partners

Related News

infographic showing findings of study

Examining how insurance coverage shapes access to kidney transplantation

Regenstrief researchers contribute to a national study highlighting differences between Medicare Advantage and traditional Medicare  For people with kidney

Tarik Yuce, MD, Jiang Bian, PhD, Serena Guo, MD, PhD, Xing He, PhD, Yu Huang, PhD

GLP-1 medications linked to greater loss of regained weight after bariatric surgery

Study involving Regenstrief researchers uses real-world evidence to evaluate an option for managing weight recurrence  People who regain weight

image of a doctor consulting with a patient

Scalable approach could improve early detection of cognitive impairment in primary care

Regenstrief-led study evaluates how existing health data and patient-reported information could help clinicians identify individuals who need further assessmentEarly

Christopher Callahan, MD

Regenstrief Institute scientist named next president and CEO of Regenstrief Foundation 

Longtime Regenstrief investigator and former IU Center for Aging Research director will assume Foundation leadership in summer 2027.  Christopher